Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia.

Haematologica - 1 May 2009

De Stefano Valerio, Za Tommaso, Rossi Elena, Fiorini Alessia, Ciminello Angela, Luzzi Claudia, Chiusolo Patrizia, Sica Simona, Leone Giuseppe

Abstract excerpt

It is uncertain whether the JAK2 V617F mutation increases the thrombotic risk in patients with essential thrombocythemia, and it is unknown whether inherited thrombophilia is an additive risk factor in mutated subjects. We studied 132 patients with essential thrombocythemia, 38 of them (29%) with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Aged, 80 and over
Share to Amino Acid Substitution

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Janus Kinase 2

Share to Thrombocythemia, Essential

Share to Thrombophilia

Share to Thrombosis

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 19336736
DOI: 10.3324/haematol.13869
PMCID: PMC2675688

Genes

JAK2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-19336736-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia.PMID 19336736Read ↗

The impact of JAK2V617F mutation on different types of thrombosis risk in patients with essential thrombocythemia: a meta-analysis.Semantic proximity Read ↗

Risk of thrombosis in patients with essential thrombocythemia and polycythemia vera according to JAK2 V617F mutation statusSemantic proximity Read ↗

Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history.Semantic proximity Read ↗

Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: a systematic review.Semantic proximity Read ↗

Predictive factors of thrombosis for patients with essential thrombocythaemia: A single center study.Semantic proximity Read ↗

JAK2 V617F mutation in essential thrombocythemia: correlation with clinical characteristics, response to therapy and long-term outcome in a cohort of 275 patients.Semantic proximity Read ↗

JAK2 mutation status, hemostatic risk factors and thrombophilic factors in essential thrombocythemia (ET) patients.Semantic proximity Read ↗

High prevalence of arterial thrombosis in JAK2 mutated essential thrombocythaemia: independence of the V617F allele burden.Semantic proximity Read ↗

JAK2V617F allele burden and thrombosis: a direct comparison in essential thrombocythemia and polycythemia vera.Semantic proximity Read ↗

Risk factors for thrombosis and bleeding and their influence on therapeutic decisions in patients with essential thrombocythemia.Semantic proximity Read ↗

Is JAK2 V617F mutation more than a diagnostic index? A meta-analysis of clinical outcomes in essential thrombocythemia.Semantic proximity Read ↗

JAK2V617F mutation and circulating extracellular vesicles in essential thrombocythemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.